{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:50:27Z","timestamp":1779360627349,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.drugalcdep.2020.108158","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T11:57:32Z","timestamp":1593691052000},"page":"108158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Prevalence and correlates of obstructive lung disease among people who inject drugs, San Diego, California"],"prefix":"10.1016","volume":"214","author":[{"given":"Hayley J.","family":"Koslik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jisha","family":"Joshua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jazmine","family":"Cuevas-Mota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Goba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eyal","family":"Oren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John E.","family":"Alcaraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3663-7153","authenticated-orcid":false,"given":"Richard S.","family":"Garfein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2020.108158_bib0005","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/clinids\/20.6.1467","article-title":"Injection drug use and human immunodeficiency virus infection","volume":"20","author":"Alcabes","year":"1995","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0010","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1080\/00325481.2017.1301190","article-title":"Pathophysiology of dyspnea in COPD","volume":"129","author":"Anzueto","year":"2017","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0015","doi-asserted-by":"crossref","first-page":"425","DOI":"10.5588\/ijtld.16.0434","article-title":"Mycobacterium tuberculosis infection among persons who inject drugs in San Diego, California","volume":"21","author":"Armenta","year":"2017","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0020","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/thoraxjnl-2017-210722","article-title":"Smoking duration alone provides stronger risk estimates of chronic obstructive pulmonary disease than pack-years","volume":"73","author":"Bhatt","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0025","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijid.2014.12.016","article-title":"Tuberculosis and chronic respiratory disease: a systematic review","volume":"32","author":"Byrne","year":"2015","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0030","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1378\/chest.130.1.108","article-title":"Advanced emphysema in African-American and white patients: do differences exist?","volume":"130","author":"Chatila","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0035","first-page":"145","article-title":"[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]","volume":"41","author":"Chinese Center for Disease Control and Prevention","year":"2020","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0040","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3109\/10826089909037240","article-title":"Health care need and utilization: a preliminary comparison of injection drug users, other illicit drug users, and nonusers","volume":"34","author":"Chitwood","year":"1999","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0045","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/105504901750227804","article-title":"Interest in smoking cessation among injection drug users","volume":"10","author":"Clarke","year":"2001","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0050","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1378\/chest.130.5.1326","article-title":"Increased COPD among HIV-positive compared to HIV-negative veterans","volume":"130","author":"Crothers","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0055","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1164\/rccm.201007-1125OC","article-title":"Risk factors for chronic obstructive pulmonary disease in a European cohort of young adults","volume":"183","author":"de Marco","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0060","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.rmed.2005.09.019","article-title":"Racial and gender differences in susceptibility to tobacco smoke among patients with chronic obstructive pulmonary disease","volume":"100","author":"Dransfield","year":"2006","journal-title":"Respir. Med."},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0065","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2147\/COPD.S15968","article-title":"Prevalence and risk factors for unrecognized obstructive lung disease among urban drug users","volume":"6","author":"Drummond","year":"2011","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0070","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/thoraxjnl-2011-200702","article-title":"Association between obstructive lung disease and markers of HIV infection in a high-risk cohort","volume":"67","author":"Drummond","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0075","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.healun.2004.01.023","article-title":"Pulmonary embolization of microcrystalline cellulose in a lung transplant recipient","volume":"24","author":"Fields","year":"2005","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0080","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1164\/rccm.201011-1928OC","article-title":"Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and african american race in the COPDGene study","volume":"184","author":"Foreman","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0085","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/01.MP.0000062653.65441.DA","article-title":"Embolized crospovidone (poly[N-vinyl-2-pyrrolidone]) in the lungs of intravenous drug users","volume":"16","author":"Ganesan","year":"2003","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0090","series-title":"Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2018 Report)","author":"Global Initiative for Chronic Obstructive Lung Disease","year":"2018"},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0095","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.2147\/COPD.S159834","article-title":"Mortality in COPD patients according to clinical phenotypes","volume":"13","author":"Golpe","year":"2018","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"issue":"Spec. No","key":"10.1016\/j.drugalcdep.2020.108158_bib0100","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1148\/radiographics.22.suppl_1.g02oc01s119","article-title":"Thoracic complications of illicit drug use: an organ system approach","volume":"22","author":"Gotway","year":"2002","journal-title":"Radiographics"},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0105","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1155\/2012\/617531","article-title":"Intravascular talcosis due to intravenous drug use is an underrecognized cause of pulmonary hypertension","volume":"2012","author":"Griffith","year":"2012","journal-title":"Pulm. Med."},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0110","first-page":"235","article-title":"The clinical and economic burden of chronic obstructive pulmonary disease in the USA","volume":"5","author":"Guarascio","year":"2013","journal-title":"Clinicoecon. Outcomes Res."},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1465-9921-13-13","article-title":"\u201cGOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study\u201d","volume":"13","author":"G\u00fcder","year":"2012","journal-title":"Respir. Res."},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0120","series-title":"Deaths: Leading Causes for 2016","author":"Heron","year":"2018"},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.drugpo.2017.06.006","article-title":"Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California","volume":"47","author":"Horyniak","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0130","first-page":"554","article-title":"[Prevalence of chronic obstructive pulmonary disease and risk factors in smokers and ex-smokers]","volume":"39","author":"Jaen Diaz","year":"2003","journal-title":"Arch. Bronconeumol."},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0135","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/pubmed\/fdh189","article-title":"High rates of primary care and emergency department use among injection drug users in Vancouver","volume":"27","author":"Kerr","year":"2004","journal-title":"J. Public Health Oxf. (Oxf)"},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0140","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0379-0738(87)90083-1","article-title":"The nature and the occurrence of birefringent material in different organs in fatal drug addiction","volume":"34","author":"Kringsholm","year":"1987","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0145","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/jcp.25.10.876","article-title":"Starch and talc emboli in drug addicts\u2019 lungs","volume":"25","author":"Lamb","year":"1972","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0150","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1378\/chest.10-1253","article-title":"COPD in never smokers: results from the population-based burden of obstructive lung disease study","volume":"139","author":"Lamprecht","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0155","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1747-597X-8-35","article-title":"Qualitative investigation of barriers to accessing care by people who inject drugs in Saskatoon, Canada: perspectives of service providers","volume":"8","author":"Lang","year":"2013","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0160","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1513\/pats.201006-045WR","article-title":"HIV and chronic obstructive pulmonary disease: is it worse and why? Proc","volume":"8","author":"Morris","year":"2011","journal-title":"Am. Thorac. Soc."},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0165","unstructured":"National Heart Lung and Blood Institute, COPD. Retrieved from https:\/\/www.nhlbi.nih.gov\/health-topics\/copd (Accessed on 1 June 2020)."},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0170","series-title":"COVID-19: Potential Implications for Individuals With Substance Use Disorders","author":"National Institute on Drug Abuse (NIDA)","year":"2020"},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0175","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2524.2007.00739.x","article-title":"Barriers to accessing generic health and social care services: a qualitative study of injecting drug users","volume":"16","author":"Neale","year":"2008","journal-title":"Health Soc. Care Community"},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0180","doi-asserted-by":"crossref","first-page":"W506","DOI":"10.2214\/AJR.14.12582","article-title":"Pulmonary effects of IV injection of crushed oral tablets: \u201cExcipient lung disease\u201d","volume":"203","author":"Nguyen","year":"2014","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0185","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.2147\/COPD.S146390","article-title":"Gender-specific estimates of COPD prevalence: a systematic review and meta-analysis","volume":"13","author":"Ntritsos","year":"2018","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0190","series-title":"Respiratory Diseases","author":"Office of Disease Prevention and Health Promotion","year":"2019"},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0195","doi-asserted-by":"crossref","first-page":"113096","DOI":"10.1016\/j.psychres.2020.113096","article-title":"The COVID-19 pandemic and its impact on substance use: implications for prevention and treatment","volume":"289","author":"Ornell","year":"2020","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0200","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1164\/ajrccm\/139.1.233","article-title":"Long-term follow-up of drug abusers with intravenous talcosis","volume":"139","author":"Par\u00e9","year":"1989","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0205","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s11524-008-9336-1","article-title":"Medicaid patients at high risk for frequent hospital admission: real-time identification and remediable risks","volume":"86","author":"Raven","year":"2009","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0210","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1477-7517-11-4","article-title":"Evaluating the impact of Mexico\u2019s drug policy reforms on people who inject drugs in Tijuana, B.C., Mexico, and San Diego, CA, United States: a binational mixed methods research agenda","volume":"11","author":"Robertson","year":"2014","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0215","first-page":"1107","article-title":"Update. American thoracic society","volume":"152","author":"Standardization of Spirometry","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0220","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2214\/ajr.174.3.1740789","article-title":"Talcosis associated with IV abuse of oral medications: CT findings","volume":"174","author":"Ward","year":"2000","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0225","series-title":"Employment and Activity Limitations Among Adults With Chronic Obstructive Pulmonary Disease \u2014 United States, 2013","author":"Wheaton","year":"2015"},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0230","series-title":"Chronic Obstructive Pulmonary Disease (COPD)","author":"World Health Organization (WHO)","year":"2017"},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0235","series-title":"The Top 10 Causes of Death","author":"World Health Organization (WHO)","year":"2018"},{"key":"10.1016\/j.drugalcdep.2020.108158_bib0240","series-title":"Asthma","author":"World Health Organization (WHO)","year":"2019"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620303239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620303239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:04:15Z","timestamp":1759827855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871620303239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":48,"alternative-id":["S0376871620303239"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108158","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and correlates of obstructive lung disease among people who inject drugs, San Diego, California","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108158","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108158"}}